Salomon, Benoit L. http://orcid.org/0000-0001-9673-5578
Article History
Accepted: 21 May 2021
First Online: 5 July 2021
Competing interests
: B.L.S. declares that he received consultancy fees from HiFiBio Therapeutics regarding the applications of TNFR2 agonists and antagonists in cancer and autoimmunity.